Trial record 1 of 1 for:    MM08-141
Previous Study | Return to List | Next Study

Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by Hoosier Cancer Research Network
Sponsor:
Collaborators:
Hoosier Cancer Research Network
Cephalon
Information provided by (Responsible Party):
Sherif Farag, MB, BS, Hoosier Cancer Research Network
ClinicalTrials.gov Identifier:
NCT01177683
First received: August 5, 2010
Last updated: December 28, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)